tiprankstipranks
Trending News
More News >
ASKA Pharmaceutical Holdings Co., Ltd. (JP:4886)
:4886
Japanese Market
Advertisement

ASKA Pharmaceutical Holdings Co., Ltd. (4886) Ratios

Compare
0 Followers

ASKA Pharmaceutical Holdings Co., Ltd. Ratios

JP:4886's free cash flow for Q1 2025 was ¥0.45. For the 2025 fiscal year, JP:4886's free cash flow was decreased by ¥ and operating cash flow was ¥0.09. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.51 2.34 3.05 3.10 2.39
Quick Ratio
1.27 1.49 2.04 2.15 1.53
Cash Ratio
0.29 0.57 0.82 0.76 0.63
Solvency Ratio
0.22 0.35 0.23 0.21 0.16
Operating Cash Flow Ratio
0.00 0.06 0.19 0.18 0.39
Short-Term Operating Cash Flow Coverage
0.00 0.30 0.97 1.65 2.47
Net Current Asset Value
¥ 21.94B¥ 27.33B¥ 21.15B¥ 15.15B¥ 1.86B
Leverage Ratios
Debt-to-Assets Ratio
0.13 0.10 0.14 0.17 0.20
Debt-to-Equity Ratio
0.21 0.15 0.23 0.29 0.37
Debt-to-Capital Ratio
0.17 0.13 0.19 0.22 0.27
Long-Term Debt-to-Capital Ratio
0.13 0.07 0.14 0.20 0.24
Financial Leverage Ratio
1.57 1.47 1.60 1.70 1.86
Debt Service Coverage Ratio
1.51 2.04 2.04 3.26 2.26
Interest Coverage Ratio
55.55 162.50 102.16 85.63 61.19
Debt to Market Cap
0.23 0.16 0.38 0.39 0.40
Interest Debt Per Share
488.58 336.42 448.78 497.07 579.96
Net Debt to EBITDA
0.99 -0.34 -0.23 0.25 0.84
Profitability Margins
Gross Profit Margin
47.38%48.80%47.28%46.55%46.00%
EBIT Margin
7.50%15.76%8.94%10.99%6.54%
EBITDA Margin
11.10%20.00%13.62%13.57%12.63%
Operating Profit Margin
7.53%10.34%8.45%8.47%6.54%
Pretax Profit Margin
9.08%15.69%8.86%10.89%6.48%
Net Profit Margin
7.56%12.01%7.01%7.58%4.92%
Continuous Operations Profit Margin
7.71%12.01%7.01%7.58%4.92%
Net Income Per EBT
83.25%76.51%79.11%69.61%75.89%
EBT Per EBIT
120.55%151.72%104.87%128.53%99.03%
Return on Assets (ROA)
4.93%8.31%4.86%5.15%3.29%
Return on Equity (ROE)
7.80%12.18%7.77%8.77%6.10%
Return on Capital Employed (ROCE)
6.26%9.73%7.35%7.13%5.48%
Return on Invested Capital (ROIC)
5.04%6.93%5.54%4.84%4.00%
Return on Tangible Assets
5.26%8.59%5.13%5.56%3.84%
Earnings Yield
8.34%12.34%12.62%11.97%6.55%
Efficiency Ratios
Receivables Turnover
4.18 4.03 3.97 3.91 4.20
Payables Turnover
4.86 4.37 11.23 9.70 4.62
Inventory Turnover
1.28 1.58 1.80 2.01 2.07
Fixed Asset Turnover
3.38 5.58 5.60 5.18 4.35
Asset Turnover
0.65 0.69 0.69 0.68 0.67
Working Capital Turnover Ratio
1.95 1.84 1.74 2.00 2.54
Cash Conversion Cycle
297.05 238.48 261.89 237.45 183.98
Days of Sales Outstanding
87.23 90.48 91.86 93.38 87.00
Days of Inventory Outstanding
284.99 231.42 202.53 181.69 176.04
Days of Payables Outstanding
75.16 83.43 32.50 37.62 79.07
Operating Cycle
372.22 321.91 294.39 275.07 263.05
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 52.48 118.67 100.18 230.55
Free Cash Flow Per Share
0.00 1.17 92.25 16.39 191.64
CapEx Per Share
0.00 51.32 26.42 83.79 38.91
Free Cash Flow to Operating Cash Flow
0.00 0.02 0.78 0.16 0.83
Dividend Paid and CapEx Coverage Ratio
0.00 0.66 2.80 1.02 4.12
Capital Expenditure Coverage Ratio
0.00 1.02 4.49 1.20 5.92
Operating Cash Flow Coverage Ratio
0.00 0.16 0.27 0.20 0.40
Operating Cash Flow to Sales Ratio
0.00 0.02 0.06 0.05 0.12
Free Cash Flow Yield
0.00%0.05%7.76%1.30%13.12%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
11.99 8.11 7.92 8.35 15.28
Price-to-Sales (P/S) Ratio
0.91 0.97 0.56 0.63 0.75
Price-to-Book (P/B) Ratio
0.93 0.99 0.62 0.73 0.93
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 1.85K 12.89 77.06 7.62
Price-to-Operating Cash Flow Ratio
0.00 41.15 10.02 12.61 6.34
Price-to-Earnings Growth (PEG) Ratio
-19.98 0.10 -10.51 0.14 0.05
Price-to-Fair Value
0.93 0.99 0.62 0.73 0.93
Enterprise Value Multiple
9.16 4.53 3.85 4.92 6.79
Enterprise Value
68.19B 56.90B 31.69B 37.77B 47.33B
EV to EBITDA
9.16 4.53 3.85 4.92 6.79
EV to Sales
1.02 0.91 0.52 0.67 0.86
EV to Free Cash Flow
0.00 1.72K 12.17 81.24 8.71
EV to Operating Cash Flow
0.00 38.29 9.46 13.29 7.24
Tangible Book Value Per Share
2.21K 2.09K 1.77K 1.51K 1.15K
Shareholders’ Equity Per Share
2.31K 2.19K 1.93K 1.72K 1.57K
Tax and Other Ratios
Effective Tax Rate
0.15 0.23 0.21 0.30 0.24
Revenue Per Share
2.37K 2.22K 2.14K 2.00K 1.94K
Net Income Per Share
178.86 266.49 150.08 151.22 95.63
Tax Burden
0.83 0.77 0.79 0.70 0.76
Interest Burden
1.21 1.00 0.99 0.99 0.99
Research & Development to Revenue
0.11 0.08 0.07 0.06 0.00
SG&A to Revenue
0.00 0.21 0.22 0.22 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.00 0.20 0.63 0.46 2.41
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis